Lucy Letby’s legal team has demanded an urgent review of her convictions by the Court of Appeal following revelations that a key prosecution expert was barred from clinical practice over safety concerns during the trial.
The Guardian disclosed this week that Professor Peter Hindmarsh, a consultant paediatric endocrinologist whose testimony underpinned the conviction for the attempted murder of two babies via insulin poisoning, was excluded from clinical duties by University College London Hospitals (UCLH) in March 2023. The trust determined he posed a risk to child patients specifically regarding insulin management. The jury was never informed of this restriction, despite the prosecution describing Hindmarsh in court as the “pre-eminent expert” on the subject.
Mark McDonald, Letby’s lawyer, who has applied to the Criminal Cases Review Commission (CCRC) for a referral back to the Court of Appeal, stated that the failure to disclose this material raises fundamental questions about the safety of the convictions. “She is an innocent woman in prison, serving whole-life sentences, yet material information that could have been of critical importance to her defence was not disclosed,” McDonald said. “Did the police know? How did this information remain undisclosed? We need answers. Lucy deserves answers. She should not have to spend another day behind bars while these fundamental questions remain unanswered.”
Two senior lawyers have confirmed that serious concerns regarding an expert’s professional standing, coupled with non-disclosure to the defence, could constitute grounds for appeal. Letby’s defence team was never informed of Hindmarsh’s exclusion from clinical practice in March 2023, nor of an April 2023 Medical Practitioners Tribunal ruling imposing conditions on his registration. The Crown Prosecution Service (CPS) has also confirmed it was not made aware of these developments.
Letby was convicted of murdering seven infants and attempting to murder seven others, receiving 15 whole-life orders. Hindmarsh’s opinion that two babies had been deliberately poisoned with insulin was considered pivotal to the attempted murder convictions. Previous applications to appeal were rejected by the Court of Appeal. Since the convictions, dozens of leading medical and scientific experts from the UK and internationally have submitted reports to the CCRC arguing that the prosecution’s medical case—including Hindmarsh’s evidence—was flawed.
The Guardian investigation revealed that while the trial proceeded at Manchester Crown Court, Dr Tim Hodgson, a medical director at UCLH, wrote to the General Medical Council (GMC) stating the trust could not allow Hindmarsh to practise clinically “even under supervision” due to the risk he posed to children. Hodgson cited specific safety concerns, including two instances where Hindmarsh allegedly advised child patients to stop taking insulin. The GMC subsequently applied for Hindmarsh’s suspension, which he opposed, arguing it would impede his work as an expert witness. On 21 April 2023, a tribunal declined to suspend him but ordered direct supervision for his clinical work—a condition rendered moot by UCLH’s total ban on his patient contact.
Hindmarsh had informed Cheshire Constabulary of the GMC investigation in December 2022. The CPS disclosed this to the defence but successfully opposed the jury being informed. The jury was also not told that Hindmarsh’s contract at Great Ormond Street Hospital had been terminated in July 2022. Lead prosecution barrister Nick Johnson KC described Hindmarsh to the jury on 23 February 2023 as “the pre-eminent expert in that narrow field” of insulin. The defence remained unaware of the March and April 2023 escalations until recent reporting.
“It is staggering that Hindmarsh was presented as the pre-eminent expert on insulin at the trial, gave crucial evidence alleging babies were poisoned with insulin—which many eminent experts say was wrong—and it was never disclosed that he was considered by his own hospital to be unsafe to treat children with insulin, and barred from clinical practice,” McDonald said.
A representative for Hindmarsh declined to answer questions, including whether he disclosed the March and April developments to the police. Cheshire Constabulary declined to comment. The CPS confirmed it was never provided with the information regarding the clinical restrictions or the tribunal ruling.
Criminal Procedure Rules, introduced in 2014 following Law Commission recommendations to prevent miscarriages of justice, require expert witnesses to disclose any disciplinary proceedings that might undermine their opinion or credibility. These reforms followed notorious cases such as that of Sally Clark, who was wrongly convicted in 1999 of killing her two infant sons based partly on flawed statistical evidence from a medical expert. Clark’s convictions were overturned in 2003 after a CCRC referral revealed key medical evidence had been withheld; she died in 2007.
Tim Green KC, a specialist in disclosure law, noted that a failure to disclose material undermining an expert central to the prosecution’s case could form grounds for appeal, depending on the potential weight of that non-disclosure on the jury’s verdict. Pete Weatherby KC, a barrister with extensive criminal trial experience, emphasized that expert evidence was pivotal in the Letby prosecution because there was no direct or forensic evidence linking her to the criminal acts. “Serious concerns about an expert’s conduct or judgment may be highly relevant to assessing their expertise, credibility, and the reliability of their evidence,” Weatherby said. “If those concerns were not before the jury, that could be very significant for an appeal. If the full details were not obtained by the prosecution and disclosed to the defence at the time, that would be even more significant.”
Also Read
- Israeli Mosque Torched as Opposition Leaders Accuse Netanyahu of Fueling Tensions
- James Cleverly Secures Conservative Nomination for London Mayor Race
- Shenzhen on the World Stage: Xi Hosts Trump and Putin as APEC Joint Statement Vanishes Online
- Pyxis Oncology Reports Updated MICVO Monotherapy Data in Advanced Recurrent/Metastatic Head and Neck Cancer


